Henk Lingeman

Find an error

Name:
Organization: Vrije Universiteit Amsterdam , Belgium
Department:
Title: (PhD)
Co-reporter:Lygia Azevedo Marques, Jeroen Kool, Frans de Kanter, Henk Lingeman, Wilfried Niessen, Hubertus Irth
Journal of Pharmaceutical and Biomedical Analysis 2010 53(3) pp: 609-616
Publication Date(Web):
DOI:10.1016/j.jpba.2010.04.015
Pyridine, 4-[2-[4-(methylsulfinyl)phenyl]-5-phenyl-1H-imidazol-4-yl]-
Phenol, 4-[(E)-(5,6-dihydro[2,3'-bipyridin]-3(4H)-ylidene)methyl]-
6H-1,3-Thiazin-2-amine, 4-(1-methylethyl)-N,6-diphenyl-
PHENOL, 4-[(5,6-DIHYDRO[2,3'-BIPYRIDIN]-3(4H)-YLIDENE)METHYL]-2-METHOXY-
2,3'-Bipyridine, 3,4,5,6-tetrahydro-3-(phenylmethylene)-
6''-O-MALONYLGENISTIN
Carbamic acid, (4-bromophenyl)-,(2R,3S)-2-(3-pyridinylmethyl)-1-azabicyclo[2.2.2]oct-3-yl ester, rel-
5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-6-methyl-4-(4-nitrophenyl)-2-oxo-, methyl ester
1-METHYL-3-((2S)-1-METHYL-2-PYRROLIDINYL)PYRIDINIUM